Lynch & Associates’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-16,865
| Closed | -$1.3M | – | 102 |
|
|
2020
Q2 | $1.3M | Buy |
16,865
+295
| +2% | +$22.7K | 0.42% | 53 |
|
|
2020
Q1 | $1.24M | Buy |
16,570
+1,335
| +9% | +$99.8K | 0.46% | 50 |
|
|
2019
Q4 | $990K | Buy |
15,235
+625
| +4% | +$40.6K | 0.28% | 60 |
|
|
2019
Q3 | $926K | Sell |
14,610
-1,200
| -8% | -$76.1K | 0.28% | 57 |
|
|
2019
Q2 | $1.07M | Sell |
15,810
-1,200
| -7% | -$81.1K | 0.35% | 56 |
|
|
2019
Q1 | $1.11M | Sell |
17,010
-200
| -1% | -$13K | 0.37% | 54 |
|
|
2018
Q4 | $1.08M | Sell |
17,210
-1,925
| -10% | -$120K | 0.4% | 52 |
|
|
2018
Q3 | $1.48M | Buy |
19,135
+594
| +3% | +$45.9K | 0.5% | 49 |
|
|
2018
Q2 | $1.31M | Buy |
18,541
+1,431
| +8% | +$101K | 0.48% | 51 |
|
|
2018
Q1 | $1.29M | Buy |
17,110
+1,235
| +8% | +$93.1K | 0.49% | 50 |
|
|
2017
Q4 | $1.14M | Buy |
15,875
+1,450
| +10% | +$104K | 0.43% | 53 |
|
|
2017
Q3 | $1.17M | Buy |
+14,425
| New | +$1.17M | 0.46% | 51 |
|